daratumumab
Showing 1 - 25 of 273
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Actinium Ac 225-DOTA-Daratumumab
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)
Not yet recruiting
- Multiple Myeloma
- Iberdomide
- Daratumumab/rHuPH20 Co-formulation
- (no location specified)
Oct 25, 2023
Stem Cells Mobilization, colLection and Engraftment in Newly
Recruiting
- Multiple Myeloma
- +3 more
- Daratumumab
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)
Not yet recruiting
- Lymphoma, Primary Effusion
- Daratumumab SC
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and
Not yet recruiting
- Peripheral Neuropathy
- Monoclonal Gammopathy of Undetermined Significance
- Daratumumab and hyaluronidase-fihj
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Sep 14, 2023
Aplastic Anemia, Platelet Transfusion Refractoriness Trial in Tianjin (Daratumumab)
Recruiting
- Aplastic Anemia
- Platelet Transfusion Refractoriness
- Daratumumab
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Apr 25, 2023
Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 10, 2023
Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
-
Miami, FloridaUniversity of Miami
Oct 20, 2023
Acquired Hemophilia Trial in Tianjin (Daratumumab)
Recruiting
- Acquired Hemophilia
- Daratumumab
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
May 5, 2023
Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)
Not yet recruiting
- Hemophilia A With Inhibitor
- SCT800 and Daratumumab
- (no location specified)
May 24, 2023
Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Not yet recruiting
- Immunoglobulin Light-chain Amyloidosis
- Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- (no location specified)
Mar 18, 2023
Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life
Not yet recruiting
- Plasma Cell Myeloma
- Daratumumab and Hyaluronidase-fihj
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022
Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)
Not yet recruiting
- Refractory Multiple Myeloma
- Relapsed Multiple Myeloma
- Iberdomide
- +6 more
-
Miami, FloridaUniversity of Miami
May 31, 2023
NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,
Not yet recruiting
- Non-small Cell Lung Cancer With STK11/LKB1 Mutation
- Daratumumab and Hyaluronidase-fihj
- +2 more
-
New York, New YorkNYU Langone Health
Mar 29, 2023
Autoimmune Disorders Trial in United States (Daratumumab)
Not yet recruiting
- Autoimmune Disorders
- Daratumumab
-
Baltimore, Maryland
- +7 more
Jan 4, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma Trial in Nanjing (HLX15, US-sourced DARZALEX®, CN-sourced DARZALEX® -)
Not yet recruiting
- Multiple Myeloma
- HLX15
- +2 more
-
Nanjing, Jiangsu, ChinaSir Run Run Hospital, Nanjing Medical University
Jan 9, 2023
Glioblastoma Trial in Morgantown (Daratumumab)
Recruiting
- Glioblastoma
- Daratumumab
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022
Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)
Not yet recruiting
- Proliferative Glomerulonephritis With Monoclonal IgG Deposits
- Daratumumab
-
Rochester, MinnesotaMayo Clinic Minnesota
Dec 8, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
- +7 more
Jan 9, 2023
Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)
Recruiting
- Multiple Myeloma
- Dexamethasone
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Multiple Myeloma Trial in Rochester (procedure, biological, drug)
Not yet recruiting
- Multiple Myeloma
- Biospecimen Collection
- +12 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 15, 2023
AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,
Not yet recruiting
- AL Amyloidosis
- +2 more
- Venetoclax
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 16, 2022